2019

Professional development Vacancies
2019
Methylphenidate

Regarding amendments to the instruction for medical use of medicinal products containing methylphenidate Dear applicants! The Risk Assessment Committee in…

Read more
Levofloxacin

Dear applicants! Regarding amendments to the instruction for medical use of medicinal products containing Levofloxacin (except for the centrally authorised…

Read more
Medicinal products containing Topiramate

Dear applicants! Having reviewed the available evidence (including a cumulative review by registration certificate holders), bilateral uveitis cases were reported that developed shortly after the start of…

Read more
Medicinal products containing Temozolomide

Dear applicants! Having considered the available evidence in EudraVigilance and the literature, as well as the known association of temozolomide with severe skin reactions, the committee for…

Read more
Medicinal products containing Sulfasalazine

Dear applicants! Based on the assessment of the available data (literature, EudraVigilance), the Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (PRAC) considers…

Read more
Medicinal products containing Rivaroxaban

Dear applicants! Having considered the final results of the prematurely terminated GALILEO study, available evidence from clinical trials and spontaneous reports, the committee on the assessment of…

Read more
On amendments to the instructions for medical use of medicinal products containing Loperamide – Brugada syndrome in the context of overdose

Dear applicants! Based on a review of data on the risk of Brugada syndrome after the use of loperamide, the Pharmacovigilance Risk Assessment Committee…

Read more
Tianeptine

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the evaluation of the analysis of Periodic Safety Update Reports (PSURs) for…

Read more
Adapalene

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the evaluation of the analysis of Periodic Safety Update Reports (PSURs) for…

Read more
Everolimus (indicated for rejection of transplanted organs)

Dear applicants! The Pharmacovigilance Risk Assessment Committee (PRAC), based on the evaluation of the analysis of Periodic Safety Update Reports (PSURs) for…

Read more